2018
May 2018
MR-proADM in Urinary Tract Infections
Objectives: Febrile urinary tract infections (fUTI) can often be treated safely with oral antimicrobials in an outpatient setting. However, a minority of patients develop complications that may progress into septic shock.
Read the full publication here >
May 2018
MR-proADM in Sepsis
An early identification of sepsis patients likely to progress towards multiple organ failure is crucial in order to initiate targeted therapeutic strategies to decrease mortality.
Read the full publication here >
April 2018
MR-proADM in Sepsis and Cancer
Sepsis and bloodstream infections remain a leading cause of death in immunocompromised patients with cancer. The management of these serious infections consist of empiric use of antimicrobial agents which are often overused.
Read the full publication here >
March 2018
MR-proADM in Cardiology
Adrenomedullin (AM), a peptide isolated from an extract of human pheochromocytoma, comprises 52 amino acids with an intramolecular disulfide bond and amidation at the carboxy-terminus.
Read the full publication here >
March 2018
MR-proADM in community-acquired pneumonia (CAP)
Background: To evaluate the prognostic accuracy of proadrenomedullin (proADM) in comparison with and in addition to the Multidimensional Prognostic Index (MPI), a validated predictive tool for mortality derived from a comprehensive geriatric assessment (CGA) to predict one-month mortality risk in older patients hospitalized with community-acquired pneumonia (CAP).
Read the full publication here >
March 2018
MR-proADM in Sepsis
In collaboration with the SepNet Critical Care Trials Group, a new analysis of 1089 patients with sepsis and septic shock across 33 German Intensive Care Units was recently published in Critical Care. MR-proADM could add significant value to identifying patients at risk of further disease progression, the earlier escalation of therapy in patients at risk of treatment failure, and the subsequent de-escalation of treatment and early discharge of low risk patients.
Read the News Press Release here >
Read the full publication here >
February 2018
MR-proADM in the Laboratory
Robust reference intervals for MR-proADM concentrations in plasma were generated, with the recommended adoption of single reference intervals for the adult population as a whole.
Read the full publication here >
January 2018
MR-proADM in Paediatrics
Objectives: Community-acquired pneumonia (CAP) in children is one of the most important causes of mortality and morbidity in developing countries. Therefore, it is very important for clinicians to detect the presence and severity of pneumonia.
Read the full publication here >
January 2018
MR-proADM in the Laboratory
MR-proADM reference values in a healthy population using serum samples
Read the full publication here >
Sepsis / Emergency Department (ED)
